The current study, a randomized, double-blind, placebo-controlled trial, will assess the efficacy and safety of adjuvanted FLU-v administered as 2 vaccinations or 1 vaccination vs placebo prior to intranasal challenge with the Influenza A 2009 H1N1 human virus.